Time-related effects of cytomegalovirus infection on the development of chronic renal allograft rejection in a rat model

Intervirology

Volumn 42, Issue 5-6, 1999, Pages 279-284

  Lautenschlager, Irmeli ^a   Soots, Anu ^b   Krogerus, Leena ^b   Inkinen, Kaija ^b   Kloover, Jeroen ^b   Loginov, Raisa ^b   Holma, Kaisa ^b   Kauppinen, Harri ^b   Bruggeman, Cathrien ^b   Ahonen, Juhani ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b NONE

Author keywords

Chronic rejection; CMV; Renal transplantation

Indexed keywords

BETA1 INTEGRIN; CELL ADHESION MOLECULE; COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; BLOOD VESSEL WALL; COLLAGEN SYNTHESIS; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS INFECTION; INFLAMMATION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; RAT;

CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS;

EID: 0342680023     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000053961     Document Type: Conference Paper

References (53)

1. Rubin RH: Impact of cytomegalovirus infection on organ transplant recipients. Rev Infect Dis 1990;12(suppl 7):S754-S766.
2. Richardson WP, Colvin BB, Cheeseman SH, Tolkoff-Rubin NE, Herrin JT, Cosimi AB, Collins AB, Hirsch MS, McCluskey RT, Russell PS, Rubin RH: Glomerulopathy associated with cytomegalovirus viremia. N Engl Med 1981;305:57-63.
3. von Willebrand E, Pettersson E, Ahonen J, Häyry P: CMV infection, class II antigen expression, and human kidney allograft rejection. Transplantation 1986;42:364-367.
4. Poteil-Noble C, Ecochard R, Landrivon G, Donia-Maged A, Tardy J-C, Bosshard S, Colon S. Betuel H, Aymard M, Toiraine J-L: Cytomegalovirus infection - an etiological factor for rejection? Transplantation 1993;55:851-857.
5. Reinke P, Fietze E, Ode-Hakim S, Prösch S, Lippert J, Ewert R, Volk H-D: Late acute renal allograft rejection and symptomless cytomegalovirus infection Lancet 1994;344:1737-1738.
6. Häyry P, Isoniemi H, Yilmaz S, Mennander A, Lermström K, Räisänen-Sokolowski A, Koskinen P, Ustinov J, Lautenschlager I, Taskinen E, Krogerus L, Aho P, Paavonen T: Chronic graft injection. Immunol Rev 1993;134:33-81.
7. Grattan MT, Moreno-Cabral CE, Starnes VA, Over PE, Stinson EB, Shumway NE: Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989;261:3561-3566.
8. Loebe M, Schueler S, Zais O, Warnecke H, Fleck E, Hetzer R: Role of cytomegalovirus infection in the development of coronary artery disease in the transplanted heart. J Heart Lung Transplant 1990;9:707-711.
9. Koskinen P, Nieminen M, Krogerus L, Lemström K, Mattila S, Häyry P, Lautenschlager I: Cytomegalovirus infection and accelerated cardiac allograft vasculopathy in human cardiac allografts. J Heart Lung Transplant 1993;12: 724-729.
10. Kroshus TJ, Kshettry VR, Savik K, John R, Hertz MI, Boldman RM: Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation. J Thorac Cardiovasc Surg 1997;114:195-202.
11. O'Grady JG, Alexander GJM, Sutherland S, Donalson PT, Harvey F, Portmann B, Calne RY, Williams R: Cytomegalovirus infection and donor/recipient HLA-antigens: Interdependent co-factors in pathogenesis of vanishing bile duct syndrome after liver transplantation. Lancet 1988;ii:302-305.
12. Arnold JC, Portmann BC, O'Grady JG, Naoumov NV, Alexander GJM, Williams R: Cytomegalovirus infection persists in the liver graft in the vanishing bile duct syndrome. Hepatology 1992;16:285-292.
13. Lautenschlager I, Höckerstedt K, Jalanko H, Loginov R, Salmela K, Taskinen E, Ahonen J: Persistent CMV in liver allografts with chronic rejection. Hepatology 1997;25:190-194.
14. Paul LC: Chronic renal transplant loss. Kidney Int 1995;47:1491-1499.
15. von Willebrand E, Lautenschlager I, Krogerus L. Häyry P, Isoniemi H, Salmela K: Adhesion molecules and activation markers in acute rejection of human renal allografts. Transplant Immunol 1996;4:57-58.
16. Solez K, Racusen LC, Abdulkareem F, Kemeny E, von Willebrand E, Truong LD: Adhesion molecules and rejection of renal allografts. Kidney Int 1997;51:1476-1480.
17. Fuggle SV, Koo DD: Cell adhesion molecules in clinical renal transplantation. Transplantation 1998;65:763-769.
18. Springer TA: Adhesion receptors of immune system. Nature 1990;346:425-434.
19. Springer TA: Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol 1995;57:827-872.
20. Kovacs EJ: Fibrogenic cytokines: The role of immune mediators in the development of scar tissue. Immunol Today 1991;12:17-23.
21. Ito Y, Aten J, Bende R, Oemar BS, Rabelink T, Weening J, Goldschmeding R: Expression of connective tissue growth factor in human renal fibrosis. Kidney Int 1998;53:853-861.
22. Paul LC, Häyry P, Foegh M, Dennis MJ, Mihatch M, Larsson E, Fellström B: Diagnostic criteria for chronic rejection/accelerated graft atherosclerosis in heart and kidney transplants. Transplant Proc 1993;25:2022-2023.
23. Paul LC: Functional and histologic characteristics of chronic renal allograft rejection. Clin Transplant 1994;8:319-323.
24. Isoniemi H, Krogerus L, von Willebrand E, Taskinen E, Ahonen J, Häyry P: Histopathological findings in well-functioning, long-term renal allografts. Kidney Int 1992;41:155-160.
25. Isoniemi H, Taskinen E, Häyry P: Histological chronic allograft damage index accurately predicts chronic renal allograft rejection. Transplantation 1994;58:1195-1198.
26. Soots A, Lautenschlager I, Krogerus L, Saarinen O, Ahonen J: An experimental model of chronic renal allograft rejection in the rat using triple drug immunosuppression. Transplantation 1998;65:42-46.
27. Kauppinen H, Soots A, Krogerus L, Brummer T, Ahonen J, Lautenschlager I: The different expression of ICAM-1 and VCAM-1 and activation markers MHC class and 1L-2R in acute and chronic rejection of rat kidney allografts 1997;29:3150-3151.
28. Inkinen K, Soots A, Krogerus L, Lautenschlager I, Ahonen J: Collagens in chronic rejection of rat renal allografts. Transplant Proc 1997;29: 1543.
29. Lautenschlager I, Soots A, Krogerus L, Kauppinen H, Saarinen O, Bruggeman C, Ahonen J: Effect of cytomegalovirus on an experimental model of chronic renal allograft rejection under triple-drug treatment in the rat. Transplantation 1997;64:391-398.
30. Soots A, Saarinen O, Lautenschlager I, Ahonen J: Ultrasound and fine needle aspiration biopsy in the monitoring of rat kidney allograft. Transplant Proc 1995;27:3559.
31. Von Willebrand E, Lautenschlager I: Fine needle aspiration cytology in kidney liver and pancreas allografts; in Solez K, Racusen LC, Billingham M (eds): Pathology and Rejection Diagnosis in Solid Organ Transplantation. New York, Marcel Dekker 1996, pp 303-325.
32. Solez K, Axelson RA, Benediktsson H, Burdick JF, Cohen AH, Colvin RB, Croker BP, Droz D, Dunnil MS, Halloran PF, Häyry P, Jennette JC, Keown PA, Marcussen N, Mihatsch MJ, Myers BD, Nast CC, Olson S, Racusen LC, Ramos EL, Rosen S, Sachs DH, Salomon DR, Sanfolippo F, Verani R, von Willebrand E: International standardization of nomenclature and criteria for the histologic diagnosis of renal allograft rejection: The Banff classification of kidney transplant pathology. Kidney Int 1993; 44:411-422.
33. Bruggeman CA, Debie WMH, Grauls G, Majoor G, van Boven CPA: Infection of laboratory rats with a new cytomegalovirus-like virus. Arch Virol 1983;76:188-199.
34. Bruggeman CA, Meijer H, Bosman F, van Boven CP: Biology of rat cytomegalovirus infection. Intervirology 1985;24:1-9.
35. Bruning JH, Debie WHM, Dormans PHJ, Meijer H, Bruggman CA: The development and characterization of monoclonal antibodies against rat cytomegalovirus induced antigens. Arch Virol 1987;94:55-70.
36. Edwards CA, O'Bien W Jr: Modified assay for determination of hydroxyproline in a tissue hydrolysate. Clin Chim Acta 1980;104:161-167.
37. Burton K: A study of the conditions and mechanisms of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J 1956;62:315-323.
38. Chomczynski P, Sacchi N: Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
39. Glumoff V, Makela JK, Vuorio E: Cloning of cDNA for rat proalpha 1(III) collagen mRNA. Different expression patterns of type 1 and type II collagen and fibronectin genes in experimental granulation tissue. Biochem Biophys Acta 1994;1217:41-48.
40. Inkinen K, Soots A, Krogerus E, Bruggeman C, Ahonen J, Lautenschlager I: CMV increases collagen synthesis in chronic rejection in rat renal allograft. Transplant Proc 1999;31:1361.
41. Waldman WJ, Knight DA: Cytokine-mediated induction of endothelial adhesion molecule and histocompatibility leukocyte antigen expression by cytomegalovirus-activated T cells. Am J Pathol 1996;148:105-119.
42. Iwamoto GK, Monick MM, Clark BD, Auron PE, Stinski MF, Hunninghake GW: Modulation of interleukin-1b gene expression by the im mediate early genes of human cytomegalovirus. J Clin Invest 1990;85:1853-1857.
43. Geist LJ, Monick MM, Stinski MF, Hunninghake GW: Immediate early genes of human cytomegalovirus upregulate expression of the interleukin-2 and inlerleukin-2 receptor genes. Am J Respir Cell Mol Biol 1991;5:292-296.
44. Smith PD, Saini SS, Raffeld M, Manischewitz JF, Wahl SM: Cytomegalovirus induction of tumor necrosis factor-α by human monocytes and mucosal macrophages. J Clin Invest 1992; 1642-1648.
45. Haagmans BL, van den Eertwegh A, Claasen E, Horzinek MC, Schijns V: Tumor necrosis factor alpha production during cytomegalovirus infection in immunosuppressed rats. J Gen Virol 1994;75:779-787.
46. Lemström KB, Bruning JH, Bruggeman CA, Lautenschlager IT, Häyry P: Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts. J Clin Invest 1993;92:549-558.
47. Yamamoto T, Noble NA, Miller DE, Border WA: Sustained expression of TGF-beta 1 underlies development of progressive kidney fibrosis. Kidney Int 1994;45:916-927.
48. Okada H, Strutz F, Danoff TM, Neilson E: Possible pathogenesis of renal fibrosis. Kidney Int 1996;49(suppl 54):S37-S38.
49. Funayama H, Ikeda U, Takahashi M, Sakata Y, Kitagavva S, Takahashi Y, Masuyama J, Furukawa Y, Miura Y, Kano S, Matsuda M, Shimada K: Human monocyte-endothelial cell interaction induces platelet-derived growth factor expression. Cardiovasc Res 1998;37: 216-224.
50. Phan SH, Gharace-Kermani M, McGarry B, Kunkel SL, Wolber FW: Regulation of rat pulmonary artery endothelial cell transforming growth factor-β production by IL-1β and tumor necrosis factor-α J Immunol 1992;149:103-106.
51. Pintavorn P, Ballerman BJ: TGF-β and the endothelium during immune injury. Kidney Int 1997;51:1401-1412.
52. Michelson S, Alcami J, Kim SJ, Danielpour D, Bachelerec F, Picard L, Bessia C, Paya C, Virelizier JL: Human cytomegalovirus infection induces transcription and secretion of transforming growth factor beta 1. J Virol 1994;68:5730-5737.
53. Grotendorst GR: Connective tissue growth factor: A mediator of TGF-beta action on fibroblasts. Cytokine Growth Factor Rev 1997;8: 171-179.